EVALUATION OF STROKE DISPARITIES IN NATIVE HAWAIIANS AND OTHER PACIFIC ISLANDERS

夏威夷原住民和其他太平洋岛民的中风差异评估

基本信息

项目摘要

Intracerebral hemorrhage (ICH) is a devastating hemorrhagic stroke that accounts for 10-15% of the approximately 700,000 annual strokes in the Unites States and results in disproportionately high morbidity and mortality. To date, there is no definitive treatment that results in reversal of neuronal injury and improvement in outcome after ICH. Therefore, it is important to identify the high-risk group and focus on primary and secondary prevention to reduce the incidence and burden of ICH. Recent evidence suggests that the burden of ICH is not borne equally by all, with racial minority groups reported to have a higher incidence and poorer outcomes than whites. Although Native Hawaiians and other Pacific Islanders (NHPI) have been reported to have higher burden of cardiovascular diseases compared to other major racial-ethnic groups, the burden of vascular risk factors related to ICH in this population has not been adequately studied. Furthermore, long-term functional outcome and quality-of-life measures after ICH among NHPI have not been studied. The overall strategy for this project will be to build on the findings from our preliminary work on ICH disparities, utilizing the clinical and research expertise at The Queen's Medical Center, a university-affiliated hospital that is the primary tertiary referral center in the Pacific and has the largest stroke service in the state. We plan to prospectively identify patients who are hospitalized at The Queen's Medical Center for acute ICH, and assess racial disparities in clinical and sociodemographic risk factors and long-term disease-specific health-related quality of life and functional outcomes, which will be measured at 3-, 6-, and 12-month from admission. We hypothesize that NHPI race is associated with younger age of presentation with ICH, better quality of life and less disability at 3 months after ICH compared to other major racial-ethnic groups in Hawaii. In addition, we will develop and test, in a randomized controlled pilot study, the impact of a culturally-informed, stroke-specific Patient Navigation program on psychological health-related quality of life and post-stroke depression among the ICH survivors.
脑出血(ICH)是一种毁灭性的出血性中风,占10-15%, 在美国,每年约有70万人中风,导致不成比例的高发病率。 and mortality.迄今为止,还没有导致神经元损伤逆转的确定性治疗, ICH后结局改善。因此,重要的是要确定高风险群体, 一级和二级预防,以降低ICH的发生率和负担。最近的证据表明 非物质文化遗产的负担并非人人平等,据报告, 发病率和预后比白人差。夏威夷原住民和其他太平洋岛民(NHPI) 据报道,与其他主要种族相比, 在这一人群中,与ICH相关的血管危险因素负担尚未得到充分研究。 此外,NHPI患者脑出血后的长期功能结局和生活质量指标并没有 本文研究了 本项目的总体战略是以我们在非物质文化遗产方面的初步工作结果为基础 利用大学附属的女王医疗中心的临床和研究专业知识, 医院是太平洋地区的第一个三级转诊中心,拥有该州最大的中风服务。 我们计划前瞻性地识别因急性ICH而在女王医疗中心住院的患者, 并评估临床和社会人口学风险因素的种族差异以及长期疾病特异性 健康相关的生活质量和功能结局,将在3个月、6个月和12个月时进行测量, 入院我们假设NHPI种族与ICH的发病年龄相关, ICH后3个月的生活质量和残疾程度低于其他主要种族-民族组, 夏威夷。此外,我们将在一项随机对照的试点研究中开发和测试一种文化知情的, 脑卒中患者导航项目对心理健康相关生活质量和脑卒中后的影响 脑出血幸存者的抑郁症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marjorie K. Leimomi Mala Mau其他文献

Marjorie K. Leimomi Mala Mau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marjorie K. Leimomi Mala Mau', 18)}}的其他基金

The Pacific Ocean Native Observational (PONO) Health Legacy Study
太平洋原住民观测 (PONO) 健康遗产研究
  • 批准号:
    10724217
  • 财政年份:
    2023
  • 资助金额:
    $ 14.54万
  • 项目类别:
I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders
I kua nau“让我实现您最后的愿望”夏威夷原住民长者预先护理计划
  • 批准号:
    10379275
  • 财政年份:
    2020
  • 资助金额:
    $ 14.54万
  • 项目类别:
I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for NativeHawaiian Elders
I kua nau“让我实现您最后的愿望”夏威夷原住民长者的预先护理计划
  • 批准号:
    10768375
  • 财政年份:
    2020
  • 资助金额:
    $ 14.54万
  • 项目类别:
RESEARCH TRAINING AND EDUCATION CORE
研究培训和教育核心
  • 批准号:
    9369109
  • 财政年份:
    2015
  • 资助金额:
    $ 14.54万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    9369092
  • 财政年份:
    2015
  • 资助金额:
    $ 14.54万
  • 项目类别:
PROJECT 1
项目1
  • 批准号:
    9360245
  • 财政年份:
    2014
  • 资助金额:
    $ 14.54万
  • 项目类别:
PROJECT 2
项目2
  • 批准号:
    9360246
  • 财政年份:
    2014
  • 资助金额:
    $ 14.54万
  • 项目类别:
COMMUNITY CORE
社区核心
  • 批准号:
    9360229
  • 财政年份:
    2014
  • 资助金额:
    $ 14.54万
  • 项目类别:
Advancing Native Health and Wellness Conference
促进本土健康与保健会议
  • 批准号:
    8400271
  • 财政年份:
    2012
  • 资助金额:
    $ 14.54万
  • 项目类别:
COMMUNITY ENGAGED RESEARCH
社区参与研究
  • 批准号:
    8364965
  • 财政年份:
    2011
  • 资助金额:
    $ 14.54万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 14.54万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了